Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAIC(Hepatic Artery Infusion Chemotherapy)”

139 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 139 results

Testing effectiveness (Phase 2)UnknownNCT05029973
What this trial is testing

HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Study completedNCT02774187
What this trial is testing

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 247
Large-scale testing (Phase 3)Looking for participantsNCT06201065
What this trial is testing

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Large-scale testing (Phase 3)UnknownNCT05263219
What this trial is testing

DEB-TACE+HAIC vs. HAIC for Large HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 230
Testing effectiveness (Phase 2)Active Not RecruitingNCT07380633
What this trial is testing

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 90
Large-scale testing (Phase 3)UnknownNCT02767375
What this trial is testing

Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 192
Testing effectiveness (Phase 2)Looking for participantsNCT07504471
What this trial is testing

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 50
Not applicableLooking for participantsNCT07436845
What this trial is testing

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)Emotional DistressHAIC(Hepatic Artery Infusion Chemotherapy)+2 more
Nanfang Hospital, Southern Medical University 90
Large-scale testing (Phase 3)UnknownNCT03469479
What this trial is testing

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 252
Not applicableUnknownNCT04181931
What this trial is testing

Neo-TACE-HAIC for PVTT-HCC

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Sun Yat-sen University 320
Testing effectiveness (Phase 2)UnknownNCT06210334
What this trial is testing

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)

Who this might be right for
Hepatocellular Carcinoma With PVTT
Li Xiao Wei 54
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02981498
What this trial is testing

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)Study completedNCT05099848
What this trial is testing

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Post-approval studies (Phase 4)UnknownNCT01997957
What this trial is testing

A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhu Xu 110
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Testing effectiveness (Phase 2)Ended earlyNCT06739252
What this trial is testing

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma
Peking University 1
Load More Results